Victory Square Technolog... Stock Quote 6F6 - Stock Price, News, Charts, Message Board, Trades

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
Germany
TG
Victory Square Technologies Inc (6F6) Quote

Victory Square Technologies Inc (6F6)

0.0682

0.00

( 0.00% )

Updated: 07:31:38

Realtime Data

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Current Price

0.0682

Bid

0.0606

Ask

0.0726

Volume

0.00

0.00 Day's Range 0.00

0.0616 52 Week Range 0.13

Market Cap

Previous Close

0.0682

Open

-

Last Trade

Last Trade Time

-

Financial Volume

-

VWAP

-

Average Volume (3m)

4,939

Shares Outstanding

99,564,971

Dividend Yield

-

PE Ratio

-0.40

Earnings Per Share (EPS)

-0.17

Revenue

12.06M

Net Profit

-17.39M

Sector

Computer Related Svcs, Nec

Industry

Computer Related Svcs, Nec

Website

www.victorysquare.com

Headquarters

Vancouver, British Columbia, Can

Founded

1970

Victory Square Technologies Inc is listed in the Computer Related Svcs sector of the Tradegate (DE) with ticker 6F6. The last closing price for Victory Square Technolog... was 0.07 €. Over the last year, Victory Square Technolog... shares have traded in a share price range of 0.0616 € to 0.13 €.

Victory Square Technolog... currently has 99,564,971 shares outstanding. The market capitalization of Victory Square Technolog... is 6.79 € million. Victory Square Technolog... has a price to earnings ratio (PE ratio) of -0.40.

No news to show yet.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.0116	-14.5363408521	0.0798	0.0798	0.0734	1500	0.07446667	DE
4	-0.0158	-18.8095238095	0.084	0.084	0.0675999	7606	0.07069235	DE
12	-0.0016	-2.29226361032	0.0698	0.0876	0.0656	4939	0.07431209	DE
26	-0.0308	-31.1111111111	0.099	0.101	0.0616	4133	0.07801779	DE
52	-0.0618	-47.5384615385	0.13	0.13	0.0616	4684	0.08443707	DE
156	-0.0618	-47.5384615385	0.13	0.13	0.0616	4684	0.08443707	DE
260	-0.0618	-47.5384615385	0.13	0.13	0.0616	4684	0.08443707	DE

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
G1HG1 Therapeutics Inc	6.39 € (64.52%)	22.81k
5ZOLiMetal Corp	0.0748 € (36.50%)	46.77k
1RR1Rokmaster Resources Corp	0.024 € (29.73%)	411
GPI1China Oil Gas Gr	0.0305 € (27.08%)	1.5k
CYTHLumen Technologies Inc	5.80 € (26.91%)	271.49k
D4GDataMetrex AI Ltd	0.0042 € (-50.00%)	50.79k
INENIndigo Exploration Inc	0.0102 € (-49.50%)	200
5QQ0Stem Inc	0.5612 € (-38.51%)	130.54k
1N7Nevro Corp	5.00 € (-37.11%)	750
ER4Emergent Biosolns Dl 001	6.022 € (-33.04%)	15.61k
EVTEvotec SE	5.295 € (-19.89%)	3.2M
CBKCommerzbank AG	12.67 € (-4.20%)	958.03k
D7GNel ASA	0.4841 € (0.85%)	765.88k
CXGHGoldwind Science & Technology Co Ltd	0.4699 € (5.86%)	680.24k
DRHDroneShield Limited	0.587 € (-5.63%)	540.93k

Implanting

Implanting 4 minutes ago

How about this scenario. We know that in this last FMG offering, ALL THE INSIDERS bought shares. Keith, Dan, and all other insiders in the Company.
Dan made a big deal about how many shares he bought in the offering and the total amount of shares he holds in a video I watched.

redspeed

redspeed 5 minutes ago

Out with the old and in with the new…

7 Billion share being unlocked and there is NOTHING 💼hold’rs can do to stop it. Apparently mONI preyed on uneducated investors that do little to no DD and couldn’t even read the new Series B amendment let alone calculate the potential mass

RobotDroid

RobotDroid 5 minutes ago

Another maga moron rises from the scum.

gp22

gp22 6 minutes ago

$RR @ .50s: Got out in Pre-Market @ .60s: $RR a mess for whatever reason. Do whatever you have to do to get out as well.

OncoJock

OncoJock 6 minutes ago

Agree with this analysis.

Also found myself wondering, while shaving this morning, what would happen if additional CMS guidance this fall reinforces Helen and Rob Davis' perspective that combining hyaluronidase with an old drug -- and changing the route of administration -- qualifies

work-n-hard

work-n-hard 6 minutes ago

RR: Hate I missed that big drop into the close. That was a nice bounce, Congrats Mark.

12yearplan

12yearplan 6 minutes ago

Cool Sorta,.. it was a tenuous thread with a moot premise - no one should care in a pluralistic society about "those" public servants; a PROG thing lol.

https://www.reddit.com/r/punk/comments/mh4v8v/what_is_the_song_identity_by_x_ray_spex_about/

[yt]fYoiCStDTQg[

Think1st

Think1st 8 minutes ago

Were coming up to almost a year. Since ceo said they hope to close a deal by eoy 2023.

Think about your daily life when people miss a deadline. One should NOT give deadline if they can't meet it.period.
Now we wait for being thrown a bone going into quarterly report
Imo

sab63090

sab63090 8 minutes ago

Well, in the case of following accepted methods of revealing medical protocols and data we are sadly failing for whatever reason. Missling has, so far, been secretive and is not honest....I guess I need to give Investor credit for a lot of what I have picked up from him and you and I agree on many

prototype_101

prototype_101 8 minutes ago

Marco Polo posted this, worth another LQQk, he nailed it on AMF as one of the Foundries, I believe he has a couple other of them right as well!!

Following the bread crumbs might give us a sense of the possible foundry partners getting close to a possible contract. This is speculation

S-BEES-BUMBLEBEE

S-BEES-BUMBLEBEE 8 minutes ago

$TANH >>> Gaining some traction here... $$$

https://ih.advfn.com/p.php?pid=staticchart&s=AMEX%3Atanh&p=0&t=17&width=288&height=147&vol=1&delay=1&min_pre=330&min_after=240

https://www.stockscores.com/chart.asp?TickerSymbol=tanh&TimeRange=60&Interval=60&Volume=1&ChartType

RobotDroid

RobotDroid 8 minutes ago

How in the world can the FDA approve Dvax by November when nwbo has not even applied to them yet???

DD_dempsey

DD_dempsey 8 minutes ago

Agreed. It’s coming $KYNC-

Break of .001+ and then .0014+ pps and off ahe goes here. We shall see over need see weeks imo- as the updates stream in here.

mouton29

mouton29 9 minutes ago

Ocular Therapeutix™ Announces FDA Feedback That SOL-R Trial is Appropriate as a Registrational Study in Wet AMD

…

In a Type C written response, the FDA agreed that the SOL-R repeat dosing wet AMD study is appropriate as an adequate and well-controlled study in support o

Laster

Laster 9 minutes ago

Case In point why I like to take my profits when I have them. You just never know when someone will dump millions of shares and drop the stock $0.30.

It’s not about being chicken or scared. It’s about being responsible. Just FYI. Hope SGMO runs back to $1.20 for you.

cootcat

cootcat 10 minutes ago

The news is steady improvement. But like you and others will find fault and try to blow it out of proportion.

McMagyar

McMagyar 10 minutes ago

What??seriously?
This post stays up and all mine come down ? ? The vax took innocent life and still does. Doesn’t stop the covid
Doesn’t stop the spread of covid!
And they knew it made healthy children sick as hell.
How cold must this board be to silence me and allow

ModerateIntelligence

ModerateIntelligence 10 minutes ago

See you at Expert SubPenny"King".

Keep being bullish on a stock/custodian that's completely incompetent/worthless.

Twilson

Twilson 11 minutes ago

Gapping up in pre so will see if it holds or craps later. Off work so will not be at computer all day.

gorbec1

gorbec1 11 minutes ago

pepeoil

pepeoil 11 minutes ago

Yep, I doubt we are going to $15 pps, or $40 pps or $80 pps. Lol. We going toooo daaaa moooooon

RobotDroid

RobotDroid 12 minutes ago

As is everything nwbo related. Wonder why they cannot come to an easy decision??

Krombacher

Krombacher 12 minutes ago

I'm saying that Questrade allows investors with non American passports to buy shares of ERHC as does Scotia iTrade and other Canadian brokers. I said nothing about Questrade allowing you to short ERHC.

I'm realizing more and more that I seem to be more educated and sophisticated about

WeTheMarket

WeTheMarket 13 minutes ago

JB, thank you for the insightful response.

Victory Square Technolog...

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions